Pharmacie by Medi-Market Group - Evere
0636.791.538 · rovalta.com · 27/09/2026
NORMAL SITUATION
Pharmacie by Medi-Market Group - Evere
Company — Normal situation.
Strike-off: 25 juin 2026
Financial year 2025 · Closed on 31/12/2025
Net result73,3 k €+5,9 %over 1 year
Gross margin107,4 k €+2,5 %over 1 year
Equity1,2 M €+6,3 %over 1 year
Overview
Identity
Source · BCE/KBOPharmacie by Medi-Market Group - Evere is a Public limited company incorporated in 2015.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0636.791.538
- Incorporation
- 04/09/2015
- Legal form
- Public limited company
- Contributed capital
- 150 000,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 10 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 107,4 k € | +2.5% | 104,7 k € | +14.4% | 91,6 k € | +3.3% | 88,6 k € | +8.1% | 82 k € |
| EBITDA | 106,4 k € | +2.6% | 103,7 k € | +14.4% | 90,6 k € | +5.0% | 86,3 k € | +17.9% | 73,2 k € |
| Operating result | 95,1 k € | +4.7% | 90,8 k € | +17.2% | 77,5 k € | +6.6% | 72,6 k € | +23.4% | 58,9 k € |
| Net result | 73,3 k € | +5.9% | 69,2 k € | -9.7% | 76,6 k € | +32.4% | 57,9 k € | +25.9% | 46 k € |
| Balance sheet | |||||||||
| Equity | 1,2 M € | +6.3% | 1,2 M € | +6.4% | 1,1 M € | +7.6% | 1 M € | +6.1% | 951,1 k € |
| Total assets | 2,6 M € | +10.1% | 2,4 M € | +11.2% | 2,2 M € | +51.7% | 1,4 M € | -38.1% | 2,3 M € |
| Cash | 0 € | -100% | 15,4 k € | +10.9% | 13,9 k € | +2807% | 477,7 € | -95.3% | 10,1 k € |
| Debts | 1,4 M € | +13.6% | 1,2 M € | +16.1% | 1,1 M € | +160% | 412,3 k € | -69.3% | 1,3 M € |
| Other | |||||||||
| Workforce | – | – | – | 0,0 ETP | 0,0 ETP | ||||
Board of directors
Source · NBB, accounts to 31/12/20251 active · 10 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 16/03/2021 | 00 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 30/12/2020 | 00 | |
Filip Geerts | Chairman of the board of directors | 31/08/2015 → 17/06/2021 | 000 |
Filip Geerts | Director | 31/08/2015 → 17/06/2021 | 000 |
| Director | 31/08/2015 → 17/06/2021 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 02/07/2025 | 11/07/2024 | 29/08/2023 | 30/03/2023 | 28/03/2022 |
| General meeting | 29/06/2026 | 27/06/2025 | 01/07/2024 | 25/08/2023 | 30/03/2023 | 28/03/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/06/2026 | 30/06/2026 | French | |
| Abridged model | 31/12/2024 | 27/06/2025 | 02/07/2025 | French | |
| Abridged model | 31/12/2023 | 01/07/2024 | 11/07/2024 | French | |
| Abridged model | 31/12/2022 | 25/08/2023 | 29/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/03/2023 | 30/03/2023 | French | |
| Abridged model | 31/12/2020 | 28/03/2022 | 28/03/2022 | French | |
| Abridged model | 31/12/2019 | 18/12/2020 | 18/12/2020 | French | |
| Abridged model | 31/12/2018 | 17/07/2019 | 23/07/2019 | French | |
| Abridged model | 31/12/2017 | 29/06/2018 | 03/07/2018 | French | |
| Abridged model | 31/12/2016 | 15/06/2017 | 14/07/2017 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 10 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 16/03/2021 | 00 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 30/12/2020 | 00 | |
Filip Geerts | Chairman of the board of directors | 31/08/2015 → 17/06/2021 | 000 |
Filip Geerts | Director | 31/08/2015 → 17/06/2021 | 000 |
| Director | 31/08/2015 → 17/06/2021 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring02/07/2026ASSEMBLEE GENERALE EXTRAORDINAIRE - Fusion par absorption
- Restructuring07/05/2026Projet de fusion - Pouvoirs
- Other09/09/2025Renouvellement du mandat du commisaire - Pouvoirs
- Mandates06/02/2023DEMISSIONS, NOMINATIONS
- Mandates06/08/2021DEMISSIONS, NOMINATIONS
- Mandates23/03/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
- Mandates07/02/2020DEMISSIONS, NOMINATIONS
- Mandates19/11/2018DENOMINATION
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202573,3 k €↑
- 2024Annual accounts 202469,2 k €↓
- 2023Annual accounts 202376,6 k €↑
- 2022Annual accounts 202257,9 k €↑
- 2021Annual accounts 202146 k €↓
- 2018Annual accounts 2018144,6 k €↓
- 2018Name changePharmacie by Medi-Market group - Evere
- 2017Annual accounts 2017172,3 k €
- 04/09/2015IncorporationPublic limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Cicéron 7, 1140 Evere | CBE until 25/06/2026 | CBE |
| Avenue Cicéron 7, 1140 Evere | accounts 2021 → 2025 | Accounts 2025 · 2026-00244077 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Pharmacie by Medi-Market Group - Evere | CBE until 25/06/2026 | CBE |
| Pharmacie by Medi-Market group - Evere | accounts 2018 → 2025 | Accounts 2025 · 2026-00244077 |
| PharmaClic Evere | accounts 2017 | Accounts 2017 · 2018-28600229 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.